n/a
Article Publish Status: FREE
Abstract Title:

Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression.

Abstract Source:

Drug Des Devel Ther. 2017 ;11:2481-2491. Epub 2017 Aug 23. PMID: 28860718

Abstract Author(s):

Yuejun Li, Lili Gong, Ruili Qi, Qian Sun, Xinxin Xia, Haihui He, Jianshu Ren, Ouning Zhu, Debin Zhuo

Article Affiliation:

Yuejun Li

Abstract:

Paeoniflorin (PF) is an active monoterpene glycoside extracted fromPall. PF has exhibited antitumor effects in various cancer types. However, the effects of PF in pancreatic cancer are largely unexplored. Here, we showed that PF suppressed growth of pancreatic cancer cell lines Capan-1 and MIAPaCa-2 and profoundly sensitized these cells to X-ray irradiation. Through microarray analysis, we identified HTRA3, a tumor-suppressor candidate gene, as the most increased gene upon PF treatment in Capan-1 cells. Ectopic expression of HTRA3 led to reduced cell proliferation and increased expression of apoptotic protein Bax, suggesting a tumor suppressive role of HTRA3 in pancreatic cancer cells. Together, our results provide a set group of genetic proofs and biological proofs that PF inhibited pancreatic cancer growth by upregulating HTRA3.

Study Type : In Vitro Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.